The pharmaceutical industry is highly regulated and maintains strict standards of precision. Embracing automation and the advanced digital tools conceived through the principles of Pharma 4.0 aim to ...

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

Royalarc Electrodes will launch its SME IPO on February 14, offering 30 lakh shares to raise Rs 36 crore. The price band is ...

The "Mastering Pharmaceutical Document Management: Strategies for Compliance and Efficiency" training has been added to ResearchAndMarkets.com's offering. This specialized course offers a deep dive ...

Through a recent Gazette notification, the Health Ministry has informed drug manufacturers that those seeking an extension for implementing the revised Schedule M must conduct a ...

MedPharm DBA Bud & Mary's, a federally licensed cannabis research and pharmaceutical development company, continues to lead scientific advancements in cannabis-based therapeutics as the only U.S.

The Ministry of Health & Family Welfare has conditionally extended the due date for implementation of revised Schedule M ...

The government on Wednesday extended the due date for implementation of revised Schedule M -- good manufacturing practices ...

The implementation of the revised Schedule M marks a critical step towards enhancing the quality and safety of pharmaceutical ...

The Union Health Ministry has conditionally extended the deadline for implementing the revised Schedule M, a set of good manufacturing practices for small and medium pharmaceutical companies, till ...

The implementation of revised Schedule M for good manufacturing practices has been conditionally extended to December 31, ...

India's Ministry of Health & Family Welfare extends the Schedule M implementation deadline for small & medium pharma firms with turnover under Rs 250 crore till December 31, 2025.